Blood Collection segmentation by type distinguishes five device families that together underpin the market’s volume and pricing dynamics. The Vacutainer® system, comprising plastic or glass primary tubes, needle hubs, and safety adapters, dominates the segment with an estimated 55 % share, reflecting its entrenched use in high‑throughput hospital labs and its broad tube‑size portfolio. Needle‑free collection devices—including butterfly‑style safety sets and retractable‑needle systems—capture roughly 20 % of sales, driven by occupational‑safety regulations and the shift toward closed‑system workflows. Capillary collection devices, such as finger‑stick lancets and micro‑tubes, serve point‑of‑care and home‑testing markets, contributing about 12 % of revenue; their low‑volume design aligns with glucose, lipid, and infectious‑disease screening. Micro‑collection kits that bundle calibrated capillary tubes with preservatives for pediatric and pharmacokinetic studies account for 8 % of the market, reflecting niche demand for precise volume control. Finally, integrated safety devices that combine needle protection, tube sealing, and barcode integration represent a growing 5 % share, propelled by hospital automation initiatives. Collectively, these types define the market taxonomy and illustrate how product differentiation influences overall market size.
